MV-Zentrum für Onkologie und Hämatologie

Cologne 50677

3 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, Neoplasm Metastasis, Small Lymphocytic Lymphoma

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now